132 related articles for article (PubMed ID: 12355438)
1. The Mycoplasma-derived lipopeptide MALP-2 is a potent mucosal adjuvant.
Rharbaoui F; Drabner B; Borsutzky S; Winckler U; Morr M; Ensoli B; Mühlradt PF; Guzmán CA
Eur J Immunol; 2002 Oct; 32(10):2857-65. PubMed ID: 12355438
[TBL] [Abstract][Full Text] [Related]
2. Efficient mucosal delivery of the HIV-1 Tat protein using the synthetic lipopeptide MALP-2 as adjuvant.
Borsutzky S; Fiorelli V; Ebensen T; Tripiciano A; Rharbaoui F; Scoglio A; Link C; Nappi F; Morr M; Buttó S; Cafaro A; Mühlradt PF; Ensoli B; Guzmán CA
Eur J Immunol; 2003 Jun; 33(6):1548-56. PubMed ID: 12778472
[TBL] [Abstract][Full Text] [Related]
3. The Toll-like receptor ligand MALP-2 stimulates dendritic cell maturation and modulates proteasome composition and activity.
Link C; Gavioli R; Ebensen T; Canella A; Reinhard E; Guzmán CA
Eur J Immunol; 2004 Mar; 34(3):899-907. PubMed ID: 14991620
[TBL] [Abstract][Full Text] [Related]
4. The Mycoplasma-derived macrophage-activating 2-kilodalton lipopeptide triggers global immune activation on nasal mucosa-associated lymphoid tissues.
Rharbaoui F; Westendorf A; Link C; Felk S; Buer J; Gunzer M; Guzmán CA
Infect Immun; 2004 Dec; 72(12):6978-86. PubMed ID: 15557620
[TBL] [Abstract][Full Text] [Related]
5. The mucosal adjuvant macrophage-activating lipopeptide-2 directly stimulates B lymphocytes via the TLR2 without the need of accessory cells.
Borsutzky S; Kretschmer K; Becker PD; Mühlradt PF; Kirschning CJ; Weiss S; Guzmán CA
J Immunol; 2005 May; 174(10):6308-13. PubMed ID: 15879130
[TBL] [Abstract][Full Text] [Related]
6. Role of CD80 and CD86 in host immune responses to the recombinant hemagglutinin domain of Porphyromonas gingivalis gingipain and in the adjuvanticity of cholera toxin B and monophosphoryl lipid A.
Zhang P; Lewis JP; Michalek SM; Katz J
Vaccine; 2007 Aug; 25(33):6201-10. PubMed ID: 17629367
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of bronchus-associated lymphoid tissue in rats by repeated inhalation of aerosolized lipopeptide MALP-2.
Lührmann A; Tschernig T; Pabst R
Pathobiology; 2002-2003; 70(5):266-9. PubMed ID: 12771507
[TBL] [Abstract][Full Text] [Related]
8. Improved intranasal immunization with live-attenuated measles virus after co-inoculation of the lipopeptide MALP-2.
Lührmann A; Tschernig T; Pabst R; Niewiesk S
Vaccine; 2005 Sep; 23(39):4721-6. PubMed ID: 15964669
[TBL] [Abstract][Full Text] [Related]
9. The bacterial second messenger cdiGMP exhibits promising activity as a mucosal adjuvant.
Ebensen T; Schulze K; Riese P; Morr M; Guzmán CA
Clin Vaccine Immunol; 2007 Aug; 14(8):952-8. PubMed ID: 17567766
[TBL] [Abstract][Full Text] [Related]
10. Intranasal immunization of mice with CpG DNA induces strong systemic and mucosal responses that are influenced by other mucosal adjuvants and antigen distribution.
McCluskie MJ; Weeratna RD; Davis HL
Mol Med; 2000 Oct; 6(10):867-77. PubMed ID: 11126201
[TBL] [Abstract][Full Text] [Related]
11. In vivo effects of a synthetic 2-kilodalton macrophage-activating lipopeptide of Mycoplasma fermentans after pulmonary application.
Lührmann A; Deiters U; Skokowa J; Hanke M; Gessner JE; Mühlradt PF; Pabst R; Tschernig T
Infect Immun; 2002 Jul; 70(7):3785-92. PubMed ID: 12065522
[TBL] [Abstract][Full Text] [Related]
12. Fibronectin-binding protein I of Streptococcus pyogenes is a promising adjuvant for antigens delivered by mucosal route.
Medina E; Talay SR; Chhatwal GS; Guzmán CA
Eur J Immunol; 1998 Mar; 28(3):1069-77. PubMed ID: 9541603
[TBL] [Abstract][Full Text] [Related]
13. Synthetic mycoplasma-derived lipopeptide MALP-2 induces maturation and function of dendritic cells.
Weigt H; Mühlradt PF; Emmendörffer A; Krug N; Braun A
Immunobiology; 2003; 207(3):223-33. PubMed ID: 12777064
[TBL] [Abstract][Full Text] [Related]
14. Recruitment of lymphocytes and dendritic cells from the blood to the bronchoalveolar space and the draining lymph nodes after a single intrabronchial application of the lipopeptide MALP-2.
Tschernig T; Lührmann A; Pabst R
Pathobiology; 2002-2003; 70(5):260-5. PubMed ID: 12771506
[TBL] [Abstract][Full Text] [Related]
15. The member of the cyclic di-nucleotide family bis-(3', 5')-cyclic dimeric inosine monophosphate exerts potent activity as mucosal adjuvant.
Libanova R; Ebensen T; Schulze K; Bruhn D; Nörder M; Yevsa T; Morr M; Guzmán CA
Vaccine; 2010 Mar; 28(10):2249-2258. PubMed ID: 20060510
[TBL] [Abstract][Full Text] [Related]
16. Efficient immune responses against Intimin and EspB of enterohaemorragic Escherichia coli after intranasal vaccination using the TLR2/6 agonist MALP-2 as adjuvant.
Cataldi A; Yevsa T; Vilte DA; Schulze K; Castro-Parodi M; Larzábal M; Ibarra C; Mercado EC; Guzmán CA
Vaccine; 2008 Oct; 26(44):5662-7. PubMed ID: 18675866
[TBL] [Abstract][Full Text] [Related]
17. Identification of the domains of the fibronectin-binding protein I of Streptococcus pyogenes responsible for adjuvanticity.
Schulze K; Guzmán CA
FEMS Immunol Med Microbiol; 2003 Jul; 37(2-3):173-7. PubMed ID: 12832122
[TBL] [Abstract][Full Text] [Related]
18. Bis-(3',5')-cyclic dimeric adenosine monophosphate: strong Th1/Th2/Th17 promoting mucosal adjuvant.
Ebensen T; Libanova R; Schulze K; Yevsa T; Morr M; Guzmán CA
Vaccine; 2011 Jul; 29(32):5210-20. PubMed ID: 21619907
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast-stimulating lipopeptide-1 as a potential mucosal adjuvant enhances mucosal and systemic immune responses to enterovirus 71 vaccine.
Lin YL; Cheng PY; Chin CL; Huang LM; Lin SY; Chiang BL
Vaccine; 2018 Jul; 36(29):4331-4338. PubMed ID: 29891349
[TBL] [Abstract][Full Text] [Related]
20. Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at picomolar concentration.
Mühlradt PF; Kiess M; Meyer H; Süssmuth R; Jung G
J Exp Med; 1997 Jun; 185(11):1951-8. PubMed ID: 9166424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
